{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:36:06Z","timestamp":1781001366191,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ANAL. SCI."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s44211-023-00448-9","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T07:02:11Z","timestamp":1698303731000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Computational quality-by-design strategy to validate high-performance liquid chromatography method for the estimation of meloxicam in bulk dosage forms and milk samples"],"prefix":"10.1007","volume":"40","author":[{"given":"Vaskuri G. S. Sainaga","family":"Jyothi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harithasree","family":"Veerabomma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantibabu","family":"Katta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-7667","authenticated-orcid":false,"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"issue":"3","key":"448_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.58292\/CT.V13.9334","volume":"13","author":"A de la Concha-Bermejillo","year":"2021","unstructured":"A. de la Concha-Bermejillo, J. Romano, Pregnancy loss in cattle. Clin. Theriogenology 13(3), 167\u2013180 (2021). https:\/\/doi.org\/10.58292\/CT.V13.9334","journal-title":"Clin. Theriogenology"},{"issue":"9","key":"448_CR2","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.3168\/JDS.2009-2284","volume":"92","author":"S McDougall","year":"2009","unstructured":"S. McDougall, M.A. Bryan, R.M. Tiddy, Effect of treatment with the nonsteroidal anti-inflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis. J. Dairy Sci. 92(9), 4421\u20134431 (2009). https:\/\/doi.org\/10.3168\/JDS.2009-2284","journal-title":"J. Dairy Sci."},{"key":"448_CR3","doi-asserted-by":"publisher","unstructured":"van S. FJS, A. E, M. S, and H. H, (2018) \u201cAddition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer. J Dairy Sci 101 (4) 3387\u20133397 https:\/\/doi.org\/10.3168\/JDS.2017-12869.","DOI":"10.3168\/JDS.2017-12869"},{"issue":"1","key":"448_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3168\/JDS.2020-18691","volume":"104","author":"MO Caldeira","year":"2021","unstructured":"M.O. Caldeira, R.M. Bruckmaier, O. Wellnitz, Effects of local or systemic administration of meloxicam on mammary gland inflammatory responses to lipopolysaccharide-induced mastitis in dairy cows. J. Dairy Sci. 104(1), 1039\u20131052 (2021). https:\/\/doi.org\/10.3168\/JDS.2020-18691","journal-title":"J. Dairy Sci."},{"key":"448_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2022.103195","volume":"70","author":"VGSS Jyothi","year":"2022","unstructured":"V.G.S.S. Jyothi et al., Film forming topical dermal spray of meloxicam attenuated pain and inflammation in carrageenan-induced paw oedema in Sprague Dawley rats. J. Drug Deliv. Sci. Technol. 70, 103195 (2022). https:\/\/doi.org\/10.1016\/J.JDDST.2022.103195","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1\u20132","key":"448_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/J.ACA.2008.10.060","volume":"637","author":"P Jedziniak","year":"2009","unstructured":"P. Jedziniak, T. Szprengier-Juszkiewicz, M. Olejnik, In-house reference materials: 5-hydroxyflunixin and meloxicam in cow milk\u2014preparation and evaluation. Anal. Chim. Acta 637(1\u20132), 346\u2013350 (2009). https:\/\/doi.org\/10.1016\/J.ACA.2008.10.060","journal-title":"Anal. Chim. Acta"},{"issue":"6","key":"448_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1046\/j.1365-2125.2000.00206.x","volume":"49","author":"JC Mucklow","year":"2000","unstructured":"J.C. Mucklow, Martindale: the complete drug reference. Br. J. Clin. Pharmacol. 49(6), 613\u2013613 (2000). https:\/\/doi.org\/10.1046\/j.1365-2125.2000.00206.x","journal-title":"Br. J. Clin. Pharmacol."},{"key":"448_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/BS.PODRM.2019.10.006","volume":"45","author":"NY Khalil","year":"2020","unstructured":"N.Y. Khalil, K.F. Aldosari, Meloxicam. Profiles Drug Subst. Excipients Relat. Methodol. 45, 159\u2013197 (2020). https:\/\/doi.org\/10.1016\/BS.PODRM.2019.10.006","journal-title":"Profiles Drug Subst. Excipients Relat. Methodol."},{"key":"448_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/J.JMMM.2020.167571","volume":"523","author":"L Subbiah","year":"2021","unstructured":"L. Subbiah et al., Development of Meloxicam-chitosan magnetic nanoconjugates for targeting rheumatoid arthritis joints: Pharmaceutical characterization and preclinical assessment on murine models. J. Magn. Magn. Mater. 523, 167571 (2021). https:\/\/doi.org\/10.1016\/J.JMMM.2020.167571","journal-title":"J. Magn. Magn. Mater."},{"key":"448_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13551","author":"FY Han","year":"2021","unstructured":"F.Y. Han, D.A. Brockman, J.R. Nicholson, L. Corradini, M.T. Smith, \u201cPharmacological characterization of the chronic phase of the monoiodoacetate-induced rat model of osteoarthritis pain in the knee joint. Clin. Exp. Pharmacol. Physiol (2021). https:\/\/doi.org\/10.1111\/1440-1681.13551","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"issue":"3","key":"448_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11916-020-0837-2","volume":"24","author":"AD Kaye","year":"2020","unstructured":"A.D. Kaye et al., \u201cThe role of exparel plus meloxicam for postoperative pain management. Curr. Pain Headache Reports 24(3), 1\u20137 (2020). https:\/\/doi.org\/10.1007\/S11916-020-0837-2","journal-title":"Curr. Pain Headache Reports"},{"key":"448_CR12","doi-asserted-by":"publisher","unstructured":"M. Starek and J. Krzek, (2009) \u201cA review of analytical techniques for determination of oxicams, nimesulide and nabumetone,\u201d Talanta, vol. 77, no. 3. Elsevier, 925\u2013942 15 https:\/\/doi.org\/10.1016\/j.talanta.2008.09.022.","DOI":"10.1016\/j.talanta.2008.09.022"},{"key":"448_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/S43094-020-00069-3","author":"N Salunkhe","year":"2020","unstructured":"N. Salunkhe, N. Jadhav, S. Bhinge, Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study. Futur J Pharm Sci (2020). https:\/\/doi.org\/10.1186\/S43094-020-00069-3","journal-title":"Futur J Pharm Sci"},{"key":"448_CR14","doi-asserted-by":"publisher","unstructured":"C. Zhan, C. Wang, Y. Wang, H. Xie, and J. C.-B., \u201cUsing stable isotope labeled internal standard for LC\u2010MS\/MS quantitation of meloxicam in human plasma,\u201d Wiley Online Libr., Accessed: Jul. 28, 2021. [Online]. Available: https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/bmc.5217","DOI":"10.1002\/bmc.5217"},{"key":"448_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/J.JPBA.2019.03.038","volume":"170","author":"D Salazar-Rojas","year":"2019","unstructured":"D. Salazar-Rojas, A. Intilangelo, S.E. Vignaduzzo, R.M. Maggio, Development and validation of a green method for dissolution monitoring of pharmaceutical combinations. Meloxican and pridinol. J. Pharm. Biomed. Anal. 170, 228\u2013233 (2019). https:\/\/doi.org\/10.1016\/J.JPBA.2019.03.038","journal-title":"J. Pharm. Biomed. Anal."},{"key":"448_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/S11356-015-4713-2","author":"AH Nadim","year":"2015","unstructured":"A.H. Nadim, M.A. Al-Ghobashy, M. Nebsen, M.A. Shehata, Optimization of photocatalytic degradation of meloxicam using titanium dioxide nanoparticles: application to pharmaceutical wastewater analysis, treatment, and cleaning validation. Environ. Sci. Pollut. Res. (2015). https:\/\/doi.org\/10.1007\/S11356-015-4713-2","journal-title":"Environ. Sci. Pollut. Res."},{"key":"448_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/BMC.5217","author":"C Zhan","year":"2021","unstructured":"C. Zhan et al., Using stable isotope labeled internal standard for LC-MS\/MS quantitation of meloxicam in human plasma. Biomed. Chromatogr. (2021). https:\/\/doi.org\/10.1002\/BMC.5217","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"448_CR18","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1186\/2193-1801-3-95","volume":"3","author":"NK Sahoo","year":"2014","unstructured":"N.K. Sahoo, M. Sahu, P.S. Rao, N. Sandhya Rani, J.N.V. Indira Devi, G. Ghosh, Validation of assay indicating method development of Meloxicam in bulk and some of its tablet dosage forms by RP-HPLC. Springerplus 3(1), 2014 (2014). https:\/\/doi.org\/10.1186\/2193-1801-3-95","journal-title":"Springerplus"},{"key":"448_CR19","unstructured":"ICH Q8(R2), International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use pharmaceutical development q8 (r2). 2009."},{"key":"448_CR20","doi-asserted-by":"publisher","unstructured":"R. N. Dash, M. Habibuddin, T. Humaira, and A. A. Patel, (2015) \u201cApplication of Quality by Design for the Optimization of an HPLC Method to Determine Ezetimibe in a Supersaturable Self-Nanoemulsifying Formulation 38 (8) 874\u2013885 https:\/\/doi.org\/10.1080\/10826076.2014.982867.","DOI":"10.1080\/10826076.2014.982867"},{"issue":"15\u201316","key":"448_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10826076.2019.1626742","volume":"42","author":"A Jain","year":"2019","unstructured":"A. Jain, S. Beg, S. Saini, T. Sharma, O.P. Katare, B. Singh, Application of chemometric approach for QbD-enabled development and validation of an RP-HPLC method for estimation of methotrexate. J. Liq. Chromatogr. Relat. Technol. 42(15\u201316), 502\u2013512 (2019). https:\/\/doi.org\/10.1080\/10826076.2019.1626742","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"issue":"4","key":"448_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00401706.1960.10489912","volume":"2","author":"GEP Box","year":"1960","unstructured":"G.E.P. Box, D.W. Behnken, Some new three level designs for the study of quantitative variables. Technometrics 2(4), 455\u2013475 (1960). https:\/\/doi.org\/10.1080\/00401706.1960.10489912","journal-title":"Technometrics"},{"issue":"17","key":"448_CR23","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1080\/10826076.2013.840841","volume":"37","author":"PK Sahu","year":"2014","unstructured":"P.K. Sahu, C.S. Patro, \u201cApplication of chemometric response surface methodology in development and optimization of a RP-HPLC method for the separation of metaxalone and its base hydrolytic impuritiES. J Liquid Chromatograp Relat Tech 37(17), 2444\u20132464 (2014)","journal-title":"J Liquid Chromatograp Relat Tech"},{"issue":"1","key":"448_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.JCHROMB.2007.09.004","volume":"859","author":"JW Bae","year":"2007","unstructured":"J.W. Bae, M.J. Kim, C.G. Jang, S.Y. Lee, Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J. Chromatogr. B 859(1), 69\u201373 (2007). https:\/\/doi.org\/10.1016\/J.JCHROMB.2007.09.004","journal-title":"J. Chromatogr. B"},{"key":"448_CR25","unstructured":"ICH Q2 (R1), \u201cICH Topic Q 2 (R1) Validation of Analytical Procedures: Text and Methodology Step 5 note for guidance on validation of analytical procedures: text and methodology (cpmp\/ich\/381\/95) approval by cpmp november 1994 date for coming into operation,\u201d 1995. Accessed: Jul. 05, 2021. [Online]. Available: http:\/\/www.emea.eu.int"},{"key":"448_CR26","doi-asserted-by":"publisher","unstructured":"S. B. Jadhav, P. S. Reddy, K. L. Narayanan, and P. N. Bhosale, (2017) Development of RP-HPLC, stability indicating method for degradation products of linagliptin in presence of metformin HCL by applying 2 level factorial design; and identification of impurity-VII VIII and IX and synthesis of impurity-VII. Sci Pharm 85 (3) https:\/\/doi.org\/10.3390\/SCIPHARM85030025.","DOI":"10.3390\/SCIPHARM85030025"},{"key":"448_CR27","unstructured":"26 USP, (2003) \u201cThe United Stated Pharmacopeia. Rockville, MD,\u201d United States Pharmacopeial Conv. Inc, pp. 2155\u20132156."},{"key":"448_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2020.119217","volume":"581","author":"M Cerea","year":"2020","unstructured":"M. Cerea et al., Non-uniform drug distribution matrix system (NUDDMat) for zero-order release of drugs with different solubility. Int. J. Pharm. 581, 119217 (2020). https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119217","journal-title":"Int. J. Pharm."},{"key":"448_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.CHEMPHYSLIP.2016.10.005","volume":"201","author":"A Jain","year":"2016","unstructured":"A. Jain, S.K. Jain, In vitro release kinetics model fitting of liposomes: an insight. Chem. Phys. Lipids 201, 28\u201340 (2016). https:\/\/doi.org\/10.1016\/J.CHEMPHYSLIP.2016.10.005","journal-title":"Chem. Phys. Lipids"},{"key":"448_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPS.2019.105026","volume":"138","author":"IY Wu","year":"2019","unstructured":"I.Y. Wu, S. Bala, N. \u0160kalko-Basnet, M.P. di Cagno, Interpreting non-linear drug diffusion data: utilizing Korsmeyer-Peppas model to study drug release from liposomes. Eur. J. Pharm. Sci. 138, 105026 (2019). https:\/\/doi.org\/10.1016\/J.EJPS.2019.105026","journal-title":"Eur. J. Pharm. Sci."},{"key":"448_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJBIOMAC.2018.05.130","author":"AM Moydeen","year":"2018","unstructured":"A.M. Moydeen, M.S. Ali Padusha, E.F. Aboelfetoh, S.S. Al-Deyab, M.H. El-Newehy, Fabrication of electrospun poly(vinyl alcohol)\/dextran nanofibers via emulsion process as drug delivery system: Kinetics and in vitro release study. Int. J. Biol. Macromol (2018). https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2018.05.130","journal-title":"Int. J. Biol. Macromol"},{"issue":"1","key":"448_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/J.IJPHARM.2015.07.077","volume":"494","author":"X Xu","year":"2015","unstructured":"X. Xu, M. Al-Ghabeish, Y.S.R. Krishnaiah, Z. Rahman, M.A. Khan, Kinetics of drug release from ointments: role of transient-boundary layer. Int. J. Pharm. 494(1), 31\u201339 (2015). https:\/\/doi.org\/10.1016\/J.IJPHARM.2015.07.077","journal-title":"Int. J. Pharm."},{"issue":"3","key":"448_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0168-3659(94)00085-9","volume":"34","author":"CG Varelas","year":"1995","unstructured":"C.G. Varelas, D.G. Dixon, C.A. Steiner, Zero-order release from biphasic polymer hydrogels. J. Control. Release 34(3), 185\u2013192 (1995). https:\/\/doi.org\/10.1016\/0168-3659(94)00085-9","journal-title":"J. Control. Release"},{"issue":"8","key":"448_CR34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3109\/03639049509026658","volume":"21","author":"NV Mulye","year":"1995","unstructured":"N.V. Mulye, S.J. Turco, A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dihydrate matrices. Drug Dev. Ind. Pharm. 21(8), 943\u2013953 (1995). https:\/\/doi.org\/10.3109\/03639049509026658","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"8","key":"448_CR35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jps.2600510825","volume":"51","author":"WI Higuchi","year":"1962","unstructured":"W.I. Higuchi, Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51(8), 802\u2013804 (1962). https:\/\/doi.org\/10.1002\/jps.2600510825","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"448_CR36","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/jps.2600551113","volume":"55","author":"SJ Desai","year":"1966","unstructured":"S.J. Desai, P. Singh, A.P. Simonelli, W.I. Higuchi, Investigation of factors influencing release of solid drug dispersed in inert matrices III. Quantitative studies involving the polyethylene plastic matrix. J. Pharm. Sci. 55(11), 1230\u20131234 (1966). https:\/\/doi.org\/10.1002\/jps.2600551113","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"448_CR37","first-page":"110","volume":"60","author":"NA Peppas","year":"1985","unstructured":"N.A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60(4), 110\u2013111 (1985)","journal-title":"Pharm. Acta Helv."},{"issue":"8","key":"448_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1021\/ie50260a018","volume":"23","author":"AW Hixson","year":"1931","unstructured":"A.W. Hixson, J.H. Crowell, Dependence of reaction velocity upon surface and Agitation: I\u2014theoretical consideration. Ind. Eng. Chem. 23(8), 923\u2013931 (1931). https:\/\/doi.org\/10.1021\/ie50260a018","journal-title":"Ind. Eng. Chem."},{"issue":"3","key":"448_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jps.2600520310","volume":"52","author":"PJ Niebergall","year":"1963","unstructured":"P.J. Niebergall, G. Milosovich, J.E. Goyan, Dissolution rate studies II. Dissolution of particles under conditions of rapid agitation. J. Pharm. Sci. 52(3), 236\u2013241 (1963). https:\/\/doi.org\/10.1002\/jps.2600520310","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"448_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1208\/S12248-015-9830-9","volume":"18","author":"DA Diaz","year":"2015","unstructured":"D.A. Diaz, S.T. Colgan, C.S. Langer, N.T. Bandi, M.D. Likar, L. Van Alstine, \u201cDissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations? AAPS J. 18(1), 15\u201322 (2015). https:\/\/doi.org\/10.1208\/S12248-015-9830-9","journal-title":"AAPS J."},{"key":"448_CR41","first-page":"64","volume":"20","author":"HH Moore","year":"1996","unstructured":"H.H. Moore, J.W. Flanner, Mathematical comparison of dissolution profiles. Pharm Technol 20, 64\u201374 (1996)","journal-title":"Pharm Technol"},{"issue":"4","key":"448_CR42","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1177\/009286159603000427","volume":"30","author":"T Yi Tsong","year":"1996","unstructured":"T. Yi Tsong, P. Sathe. Hammerstrom, V.P. Shah, Statistical assessment of mean differences between two dissolution data sets\u201d. Ther Innov Regul Sci. 30(4), 1105\u20131112 (1996). https:\/\/doi.org\/10.1177\/009286159603000427","journal-title":"Ther Innov Regul Sci."},{"issue":"1","key":"448_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"1975","unstructured":"K.A. Khan, The concept of dissolution efficiency. J. Pharm. Pharmacol. 27(1), 48\u201349 (1975). https:\/\/doi.org\/10.1111\/j.2042-7158.1975.tb09378.x","journal-title":"J. Pharm. Pharmacol."},{"issue":"24","key":"448_CR44","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.1021\/IE5050567","volume":"54","author":"KA Chatzizaharia","year":"2015","unstructured":"K.A. Chatzizaharia, D.T. Hatziavramidis, Dissolution efficiency and design space for an oral pharmaceutical product in tablet form. Ind. Eng. Chem. Res. 54(24), 6305\u20136310 (2015). https:\/\/doi.org\/10.1021\/IE5050567","journal-title":"Ind. Eng. Chem. Res."},{"issue":"37","key":"448_CR45","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1016\/J.CHROMA.2011.06.006","volume":"1218","author":"E Dubreil-Ch\u00e9neau","year":"2011","unstructured":"E. Dubreil-Ch\u00e9neau, Y. Pirotais, M. Bessiral, B. Roudaut, E. Verdon, Development and validation of a confirmatory method for the determination of 12 non steroidal anti-inflammatory drugs in milk using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1218(37), 6292\u20136301 (2011). https:\/\/doi.org\/10.1016\/J.CHROMA.2011.06.006","journal-title":"J. Chromatogr. A"},{"issue":"17","key":"448_CR46","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/J.CHROMA.2010.02.047","volume":"1217","author":"P Gallo","year":"2010","unstructured":"P. Gallo et al., Confirmatory analysis of nonsteroidal anti-inflammatory drugs in bovine milk by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. A 1217(17), 2832\u20132839 (2010). https:\/\/doi.org\/10.1016\/J.CHROMA.2010.02.047","journal-title":"J. Chromatogr. A"},{"issue":"46","key":"448_CR47","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1016\/J.CHROMA.2009.04.078","volume":"1216","author":"EM Malone","year":"2009","unstructured":"E.M. Malone, G. Dowling, C.T. Elliott, D.G. Kennedy, L. Regan, Development of a rapid, multi-class method for the confirmatory analysis of anti-inflammatory drugs in bovine milk using liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1216(46), 8132\u20138140 (2009). https:\/\/doi.org\/10.1016\/J.CHROMA.2009.04.078","journal-title":"J. Chromatogr. A"},{"key":"448_CR48","unstructured":"Ewp, \u201cCommittee for medicinal products for human use (CHMP) guideline on the investigation of bioequivalence discussion in the joint efficacy and quality working group adoption rev. 1 by chmp for release for consultation end of consultation rev. 1 (deadline for comments),\u201d 1997, Accessed: Jul. 28, 2021. [Online]. Available: http:\/\/www.ema.europa.eu"},{"issue":"3","key":"448_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0928-0987(95)00046-1","volume":"4","author":"P Luger","year":"1996","unstructured":"P. Luger, K. Daneck, W. Engel, G. Trummlitz, K. Wagner, Structure and physicochemical properties of meloxicam, a new NSAID. Eur. J. Pharm. Sci. 4(3), 175\u2013187 (1996). https:\/\/doi.org\/10.1016\/0928-0987(95)00046-1","journal-title":"Eur. J. Pharm. Sci."},{"key":"448_CR50","unstructured":"WHO, \u201cTechnical Report Series No. 937, Annex 7, Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish Interchangeability.,\u201d 2006."}],"container-title":["Analytical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44211-023-00448-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44211-023-00448-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44211-023-00448-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T06:22:42Z","timestamp":1707373362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44211-023-00448-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["448"],"URL":"https:\/\/doi.org\/10.1007\/s44211-023-00448-9","relation":{},"ISSN":["0910-6340","1348-2246"],"issn-type":[{"value":"0910-6340","type":"print"},{"value":"1348-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"10 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}